Greg McKee Treats Untreatable Diseases

Welcome to another episode of Action and Ambition. Today's guest is Greg McKee, Chairman, and Chief Executive Officer at Tryp Therapeutics. Tryp therapeutics is a clinical-stage biotech company bringing transformative medicines to diseases with no known treatments. Greg has an MBA in Finance/Entrepreneurial Management from The Wharton School at the University of Pennsylvania. He has considerable experience managing publicly traded pharmaceutical firms and carries a large network of life science industry partnerships with him. Join us in this episode and learn more about Greg’s mission and story!